Stryker Corporation vs Wix.Com Ltd — how do they compare? Stryker Corporation trades at $277.34 (market cap $106.24B), while Wix.Com Ltd trades at $76.35 (market cap $3.11B). The key difference: Stryker Corporation is far larger — about 34.2× Wix.Com Ltd's market cap, and Stryker Corporation pays a 1.27% dividend while Wix.Com Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 21 Days and Wix.Com Ltd for 62 Days on average.
| SYK | WIX | |
|---|---|---|
Market Cap | $106.24B | $3.11B |
Volume | 2,982,001 | 809,286 |
Sector | Health | Technology |
52-Week High | $388.35 | $145.54 |
52-Week Low | $269.75 | $40.43 |
Typical Hold Time | 21 Days | 62 Days |
Enterprise Value | $117.70B | $4.19B |
Dividend Yield | 1.27% | — |
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Wix.com (WIX) trades at $76.56, up 4.92% in the last 24 hours, with technical indicators showing a neutral to bullish bias. Revenue growth is robust, reaching $1.99B in 2025, but profitability is inconsistent, with a net income margin of -8.19% in 2026. Analyst sentiment is positive, with a consensus buy rating and a $77 price target, though recent class action lawsuits add caution.
The outlook for WIX hinges on sustaining revenue growth while improving profitability. Risks include legal challenges and volatile earnings, but strong analyst support and a solid market position offer potential upside if execution improves.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →